Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Discussion
In patients with RRMS, NEDA-4 at 1–2 years was associated with 2 times higher odds of no long-term disability progression, at 6 years compared with EDA-4, but offered no advantage over NEDA-3.

Source: Neurology Neuroimmunology and Neuroinflammation - October 12, 2022 Category: Neurology Authors: Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., Saab, G., Shah, P. Tags: Research Article Source Type: research